Dupixent 300 MG/2 ML pen 2ML
Ended Awarded Last action
- Contract number
- SPE2DR26FFL6L
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3 Part of Cencora, Inc.
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $54,609
Award facts
- Contract value 100% obligated
- $54,608.72 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a $54,608.72 delivery order by the Defense Logistics Agency on January 28, 2026, for Dupixent 300 mg/2 mL pens. This is a firm fixed-price, non-set-aside contract with an ultimate completion date of January 29, 2026, fulfilling a critical pharmaceutical supply need for military healthcare systems. The award represents a task order against AmerisourceBergen's substantial Indefinite Delivery Contract with DLA Troop Support Medical (contract number SPE2DX), valued at up to $999.9 million through December 2026, which serves as the primary vehicle for delivering comprehensive pharmaceutical products and medical supplies to support military healthcare programs globally.
AmerisourceBergen Drug Corp operates as a subsidiary of Cencora, Inc., which also maintains its own $999.9 million Indefinite Delivery Contract with DLA Troop Support Medical extending through December 2031. The company's federal contract portfolio demonstrates extensive experience supplying specialized medications across multiple therapeutic domains to the Defense Health Agency, U.S. Coast Guard, and other government healthcare systems. This delivery order for Dupixent, a specialty pharmaceutical used in treating inflammatory conditions, exemplifies the company's role as a critical vendor for federal medical procurement and its capability to efficiently fulfill government contracts for essential pharmaceutical commodities required by military treatment facilities and veterans' healthcare programs.
Quick answers
Who was awarded contract SPE2DR26FFL6L?
SPE2DR26FFL6L was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on January 28, 2026.
How much is contract SPE2DR26FFL6L worth?
The government has obligated $54,609 on SPE2DR26FFL6L.
Is contract SPE2DR26FFL6L an order under another contract?
Yes. SPE2DR26FFL6L is a delivery order under SPE2DR25D1109, an indefinite delivery contract.
Was contract SPE2DR26FFL6L competed?
The extent of competition for SPE2DR26FFL6L was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award